Prior Authorization in Family Medicine: The Broadest Load, Without the Staff

82% of appealed prior authorization denials overturned — most were never a real 'no'

Every other specialty on this list has a concentrated prior-authorization problem: one drug class, one mechanism, one documentation shape that has to be learned and scaled. Family medicine has all of them. GLP-1 agonists, brand-name statins and antihypertensives with formulary step-therapy, MRI and CT orders, durable medical equipment, specialist referrals — the PA requirements in family medicine are as wide as the scope of care.

And unlike a rheumatology or oncology practice, a typical family medicine office doesn’t have dedicated PA staff for any of it.

The numbers in family medicine

The AMA’s 2024 Prior Authorization Physician Survey is the best cross-specialty source, and it’s directly applicable here: 40% of the survey sample is primary care, making these figures representative of family medicine specifically.

On top of the standing volume, Penn LDI and AJMC tracking shows that GLP-1 prior authorization in Medicare went from under 5% of prescriptions to approximately 100% in under two years. Family medicine prescribes a significant share of GLP-1 volume.

Why family medicine is different

What it costs

The cost in family medicine is 13 hours a week of physician and staff time across drug classes where the final answer is almost always approval. At roughly $10.81 per manually processed authorization (CAQH 2023), a family medicine practice running 39 PAs a week is spending roughly $420 a week in direct processing cost — plus the clinical cost of delayed imaging, delayed GLP-1 access, and delayed referrals for patients whose treatment needed to happen faster. The 18% of denials that survive appeal represent the real utilization management; the other 82% are administrative overhead.

How to cut the wait

Family medicine’s PA problem isn’t solvable by staffing up. The solution is infrastructure: automated assembly across drug classes, so GLP-1 documentation, step-therapy histories, and imaging justifications don’t each require a separate manual effort. Artificer Health:

  1. Assembles the packet automatically for each drug class — GLP-1 comorbidity documentation, brand-name step-therapy records, imaging clinical rationale — from the patient chart.
  2. Matches it to the payer’s criteria so the first submission goes in complete, reducing the back-and-forth that produces the 82% appeal-overturn rate.
  3. Tracks pending authorizations and re-authorizations across drug classes, so nothing lapses and no approval requires a manual follow-up call.

The goal is simple: a family practice that spends its 13 hours on patients, not paperwork, for authorizations that were going to be approved regardless.

Sources: AMA 2024 Prior Authorization Physician Survey (n=1,000; sample 40% primary care — anchors directly representative of family medicine); Penn LDI / AJMC GLP-1 PA surge analyses (2024–2025); CAQH 2023 Index.

Frequently asked questions

Why does family medicine have such a high prior authorization burden?

Family medicine manages a wider range of conditions than any other specialty, which means PA requirements land across nearly every drug class: GLP-1 agonists, brand-name medications with cheaper alternatives on formulary, imaging (MRI, CT), durable medical equipment, and specialty referrals. The AMA's 2024 survey sample is 40% primary care, making the 39 PAs/week and ~13 hrs/week figures directly representative of family medicine's load.

What happened with GLP-1 prior authorization in primary care?

Before 2024, fewer than 5% of GLP-1 prescriptions in Medicare required prior authorization. By 2025, that figure reached approximately 100%. Family medicine prescribes a substantial share of GLP-1 volume — weight management and type 2 diabetes management are both primary-care conditions — so this shift hit family medicine at scale.

Can family medicine prior authorization be automated?

Yes. Because family medicine's PA burden spans many drug classes rather than one, the value is in the infrastructure: automated packet assembly for GLP-1s, step-therapy documentation for brand-name drugs, and imaging order documentation — without dedicated PA staff for each category. Artificer Health handles this end-to-end.

Stop losing clinical time to prior authorization

Artificer Health automates prior authorization end-to-end for family medicine practices — first-pass approvals in minutes, not days.

Apply for the Pilot Program →